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 Prevalence and management of coeliac disease in people with Down’s syndrome.  
People with Down’s syndrome are more likely to have coeliac disease than the general population. 
However many people continue to be undiagnosed and therefore the appropriate care to manage 
this condition is not being recommended leading to additional health complications in this group of 
people who are now living longer than they were in previous decades. The gold standard approach 
for managing coeliac disease is currently a gluten free diet, which is often difficult for family, carers 
and individuals with Down’s syndrome to truly adhere to given the number of hidden gluten’s in 
everyday foods.  
What is coeliac disease? 
Coeliac disease is an autoimmune condition causing an inflamed small intestine and digestive 
manifestations due to an adverse response to gluten in wheat, barley and rye (Radlovic, 2013).  Thus 
if left untreated not only does the small intestine mucosa show signs of chronic  inflammation and 
loss of structure which are medically described as enteropathy but other complications ensue 
including malabsorption of essential vitamins, minerals and macronutrients leading to anaemia, 
reduced bone and fat mass (Bull et al, 2011). These nutritional complications are often more severe 
in children under one year of age which manifests by low weight and delayed growth spurts in these 
children (Radlovic, 2013).  
Many individuals with coeliac disease are oligosymptomatic meaning that they may only have a few 
symptoms or mild symptoms of diarrhoea, flatulence, abdominal pain or indigestion and 
constipation (Radlovic, 2013). Others are symptom free thus making it difficult to ascertain who is 
appropriate for screening (Costa Gomes et al, 2016). Further indicators that an individual may have 
coeliac disease and thus should have their serology checked at the registered G.P practice includes 
fatigue, weight loss, mood changes, skin rashes particularly dermatitis hepetiformis (which typically 
appears on the elbows, knees and buttocks and presents as extremely itchy with small blisters), 
neurological changes, pancreatic atrophy, menstrual irregularities and tingling, numbness or swelling 
in the hands, feet, arms and lower legs (NHS choices, 2016; Venner et al, 2015).  
Prevalence of coeliac disease.  
Prevalence rates of coeliac disease in the general population have been rising over the last decade 
which is partly thought to be due to the increased awareness and uptake of screening. Current 
prevalence rates in the UK are 1-2% which is supported by international studies finding prevalence 
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ranging from 0.3% to 2.4% with rates in the Middle East and Africa increasing in correlation to the 
changes in wheat production and preparation (Noori et al, 2016). Research has found an increased 
incidence of coeliac disease in those with Wilson’s disease, diabetes (Admou et al, 2012), 
hypothyroidism, Williams syndrome (4%; Mihci et al, 2015), Turners syndrome (4%; Dias Mdo et al, 
2010) and Down’s syndrome (Henderson et al, 2007).  
Individuals with Down’s syndrome are known to be more likely to have a number of health 
conditions including cardiovascular disease, lipid metabolic disorders, recurrent infections 
particularly of the gastrointestinal tract and respiratory system (Adelekan et al, 2012; Roizen et al, 
2014; Henderson et al, 2007; Malt et al, 2013). In addition people with Down’s syndrome have 
estimated prevalence rates of 7-50% for thyroid disease, 4% for type 1 diabetes and between 2.5% 
and 33% for coeliac disease (Malt et al, 2013; Noori et al, 2016). With one UK based study reporting 
a prevalence of confirmed coeliac disease as 11% in people with Down’s syndrome (Henderson et al, 
2007). The large divergence in results from 2.5 to 33% prevalence of coeliac disease in people with 
Down’s syndrome is due to a combination of sample selection (including geographical area, 
recruitment process and size of cohort) and the screening method employed by the researchers with 
IgA-EMA markers resulting in higher prevalence rates and diagnosis confirmed by biopsy resulting in 
lower rates of diagnosis (Uibo et al, 2006). Trends across studies from a range of countries have 
pointed to a consensus of around 6% of individuals with Down’s syndrome who have coeliac disease 
(Szaflarska-Popławskaet al, 2016; Nisihara et al, 2005; Roizen et al, 2014; Goldacre et al, 2004; 
Nisihara et al, 2005). This may prove to be a conservative estimate given the known under-
representation due to atypical and latent coeliac disease (Admou et al, 2012) and diagnostic over 
shadowing within people who have cognitive impairments.  
Despite the increased prevalence of coeliac disease in people with Down’s syndrome being 
undisputed there is currently a dearth of contemporary literature to support mechanistic 
explanations and best practice for assessment, diagnosis and interventions. Internationally the 
literature available is sparse but offers some insight and highlights that further research around this 
topic is much needed.   
The increase in coeliac disease in people with Down’s syndrome is not fully understood, with 
research looking at genomics still identifying the relevant genotype within the general population. 
Genetic links between Down’s syndrome and susceptibility to coeliac disease have been suggested in 
the literature in relation to the human leukocyte antigens specifically the haplotypes HLA-DQ2 and 
HLA-DQ8 (Admou et al, 2012; Radlovic, 2013). These antigens aid the immune system by 
distinguishing between the body’s own proteins and proteins that are made by foreign bodies, in 
coeliac disease the antigens interpret gluten proteins as foreign and send out messages to attack 
these proteins with surrounding tissues getting caught in the crossfire. Other mechanisms involve 
chromosome 21 being implicated in the reduced expansion of T cells (a subtype of white blood cells) 
in the thymus, immature natural killer cells,  autoimmune regulatory gene AIRE which works to 
prevent the immune system from attacking its own internal organs (Souto-Rodríguez et al, 2014) and 
interferon receptors 1 and 2 (Abadie et al, 2011). In addition the increase in prevalence of coeliac 
disease in those with diabetes and hypothyroidism is undisputed with an increase in both 
hypothyroidism and type 1 diabetes in individuals who have Down’s syndrome (Malt et al, 2013).    
Screening for coeliac disease.  
Robust guidelines are lacking in relation to screening for coeliac disease in people with Down’s 
syndrome. However, the British Society for Gastroenterology and recent guidance from the National 
Institute of Clinical Health and Care Excellence advocate for screening for coeliac disease in people 
with Down’s syndrome (Ludvigson et al, 2014; NICE, 2015). Evidence of the increased risks in infancy 
warrants early screening as advocated for by Bulls committee (2011) who reviewed health 
supervision in children with Down’s syndrome. The pertinence of monitoring coeliac disease in 
babies with Down’s syndrome is due to the links with physical and psychomotor development as 
well as congenital anomalies (Boskovic et al, 2012; Noori et al, 2016). Further monitoring throughout 
adult life if symptoms present which indicate signs of even mild gastrointestinal disturbance is also 
needed. This is corroborated by an increased risk of morbidity and mortality in those with 
undiagnosed coeliac disease including links to cardiovascular disease, mood disorders, intestinal 
lymphoma, gastrointestinal cancer, ulcers in the small intestine and infertility (Sharr et al, 2016; 
Ludvigson, 2012; Radlovic, 2013). The later point is also significant given evidence of the increased 
risk of emergence of coeliac disease in later life in those individuals who were previously gluten 
tolerant. 
Henderson et al (2007) support the contention that annual health checks for people with a learning 
disability are ideally suited to screen for history of coeliac disease symptomology and recommend 
serological assays to be completed in those with markers as well as those with type 1 diabetes, 
thyroid disease or anaemia. In order to ensure accuracy of blood tests it is important that the person 
continues to eat a normal healthy diet that contains gluten until the blood test is completed. 
Following positive serological markers being found biopsy to investigate enteropathy of the small 
bowel is used to confirm diagnosis. In those refusing to give consent for endoscopy or if consent 
cannot be given in their best interest then total IgA and anti-tissue transglutaminase antibody (tTG) 
serological markers and assessment for HLA (DQ2 or DQ8) suffices given the sensitivity and 
specificity of these analyses when used in combination (Radlovic, 2013). 
Treatment of coeliac disease.  
Children with Down’s syndrome often prefer foods made of simple carbohydrates and have lower 
intakes of fruit, vegetables and fibre than people who do not have Down’s syndrome (Mazurek and 
Wyka, 2015; Abdallah et al, 2013). Explanations of why individuals can’t eat the preferred foods of 
cake, biscuits, pies, pizza and foods that their peers are eating are often difficult which is 
exacerbated by a lack of easy read literature on coeliac disease. In addition explanations are needed 
to explain why the individual is feeling unwell, having bloods taken and what to expect during an 
endoscopy in which biopsies of the small intestine are taken. In order to support staff and carers 
with explanations regarding screening a number of easy read leaflets and resources have been 
produced which can be accessed at easyhealth.org.uk and the learning disabilities public health 
observatory (iHaL). Community teams, primary and acute care liaison nurses working with people 
with learning disabilities are also a quality resource to provide easy read information regarding 
coeliac disease and a gluten free diet.  
Currently medicinal treatment for coeliac disease is unavailable and thus the gold standard of 
treatment remains dietary management through the removal of foods that contain barley, rye or 
wheat. A gluten free diet has been reported to reduce the increased risk of carcinoma and 
lymphoma of untreated coeliac disease as well as potential complications such as osteoporosis and 
autoimmune disease (Admou et al, 2012).  
Maintaining a gluten free diet is complicated by ingredients lists often using names of the derivatives 
of foods which contain the prolamins that can trigger gastrointestinal reactions. This includes 
semolina, durum, spelt, cous cous, farro, farina, malt, brewers yeast and hops in beer, ales and 
lagers (see Table 1 for suggested dietary changes and refer to the coeliac organisation website at  
https://www.coeliac.org.uk/gluten-free-diet-and-lifestyle/ for a more in-depth review of potentially 
harmful foods).  In addition many foods contain hidden gluten such as yoghurts, salad dressings, 
soups, gravy, crisps and meats that are seasoned with malt vinegar, soy sauce or thickened with 
wheat starch. A final word of caution revolves around the confusion caused by labelling on products 
such as the term “wheat-free” indicating that the product may contain other sources of gluten such 
as rye or barley. This can in part explain the results from Galeazzi et al’s study (2014) which reported 
that 37% of children diagnosed with coeliac disease and on a gluten free diet for over 6 months still 
had traces of gluten in their stools. 
Food labels indicating the product is gluten free must meet the Food Advisory Committees standards 
of having less than 20 parts per million of gluten (as of 2014), which is deemed adequate for the 
majority of individuals with coeliac disease. If symptoms persist then a dietician should be consulted 
in order to discuss potential hidden glutens in the diet, cross contamination from other food sources 
and treatment for refractory coeliac disease. 
 
Table 1: Common foods that contain gluten and alternative foods.  
Foods that contain gluten Alternative options. 
Breads, pasta, noodles. 
 
 














Vegetarian meet free substitutes.  
 
Gluten free bread, rice, potato, quinoa, millet or 
buckwheat. 
 
Fruit and vegetable crudités. Chocolate bars that do not 
contain biscuit pieces, sweets.  
 
 
Oats, puffed rice or cornflakes that are not processed in 
factories that manufacture cereals containing gluten. 
Scrambled eggs and toast made from gluten free bread.  
 
 
Processed foods that state gluten free on packaging or 
meat, fish and seafood without added coatings.  
Homemade potato wedges and  
 
 
Vegetables, beans, legumes and nuts.  
  
 Further monitoring and conclusions.  
Regular monitoring of symptomology and nutritional status is required for those with a diagnosis of 
coeliac disease. This is particularly pertinent if the individual is deficient in micronutrients caused by 
malabsorption from the gluten sensitivity and can often be easily corrected with supplementation. 
Lactose intolerance has been found to have an increased risk ratio to coeliac disease (Chiu et al, 
2016) thus reducing milk based products if the individual has lactose intolerance will also aid 
absorption of essential vitamins and minerals. Monitoring should consider if the individual has 
unintentionally lost weight, are often tired, look pale or have other signs of anaemia (Bhat et al, 
2013). In addition annual health checks are a prime opportunity for the GP to review if additional 
blood test and a DEXA scan of the individuals bone density are required. The GP should also consider 
Exercise to complete: Making your own food board to encourage good food choices. 
Encourage the individual to think about some of the foods that they like but are unable to eat 
on the gluten free diet. Place pictures of these foods in the left column then discuss any 
symptoms that they have after eating these foods which can be matched to the picture above 
the food. 
                           
  




Ask the individual to choose pictures of alternative foods that can be eaten instead of the 
food that will make them unwell.  Place these pictures in column 2.  
The collage can be laminated to make a place mat or stuck on the fridge so that others can 
see it and offer options that the person likes and has chosen as an alternative 
other long term complications and the need for specialist referrals to dieticians or specialised 
consultants (NICE, 2015).   
Individuals who support people with Down’s syndrome from primary and acute care doctors to staff 
and family members should be aware of and consider the additional health complications such as 
coeliac disease which are highly prevalent in people with Down’s syndrome. In order to enhance 
their health through the life stages via supporting them to adequately manage their diet if found to 
have coeliac disease or nutritional deficiencies. Dietary modifications can not only reduce the 
symptomology of coeliac disease which can be painful for the person but also decrease the risk of 
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Implications for practice.     
• Raising awareness of the symptoms of coeliac disease in 
order to monitor for health concerns.  
·  Use easy to read or alternative resources for people with a 
learning disability to explain coeliac disease and gluten free diets. 
Which are free to download from easy health organization and 
improving health and lives or from local learning disability 
community teams.   
• Regular screening for coeliac disease should be completed 
annually as part of the annual health review with the individuals 
GPs.  
• Encourage a gluten free diet to manage coeliac disease. 
Offer the individual alternative options that they enjoy eating and 
encourage them to make good food choices. 
• Raise awareness of hidden glutens in food which may cause 
adverse reactions. 
• Review symptoms, anemia, bone density, weight loss and 
micronutrient deficiencies at least annually as part of health check 
with the registered G.P. or before this date if concerns have been 
raised. 
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